The first participant in the DRF phase has been dosed in Canada. "ALS is a devastating, fatal neurodegenerative disease with a large unmet medical need. Our mission is to make a meaningful difference ...

While there is no cure, recognizing the early signs allows for proactive management, enabling individuals and families to ...